CN107353347A - A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof - Google Patents
A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof Download PDFInfo
- Publication number
- CN107353347A CN107353347A CN201710676594.1A CN201710676594A CN107353347A CN 107353347 A CN107353347 A CN 107353347A CN 201710676594 A CN201710676594 A CN 201710676594A CN 107353347 A CN107353347 A CN 107353347A
- Authority
- CN
- China
- Prior art keywords
- ifn
- pig
- interferon
- fusion protein
- porcine
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/56—IFN-alpha
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/555—Interferons [IFN]
- C07K14/57—IFN-gamma
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
- C12N15/62—DNA sequences coding for fusion proteins
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/70—Vectors or expression systems specially adapted for E. coli
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/31—Fusion polypeptide fusions, other than Fc, for prolonged plasma life, e.g. albumin
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2800/00—Nucleic acids vectors
- C12N2800/22—Vectors comprising a coding region that has been codon optimised for expression in a respective host
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- General Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Biomedical Technology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- Biotechnology (AREA)
- Wood Science & Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Plant Pathology (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Peptides Or Proteins (AREA)
- Virology (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
Abstract
The invention discloses a kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof; the fusion protein is connected by pig albumin, Porcine interferon-gamma and porcine interferon alpha and formed through flexible linker, through being freeze-dried to obtain Recombinant Swine long-acting interferon after fusion protein and freeze drying protectant mixture.The Recombinant Swine long-acting interferon is remarkably improved the half-life period of pig interferon, and the half-life period of more common pig interferon improves more than 24 times, and with broad-spectrum disease resistance toxic action and can improve the immune response of pig itself.
Description
Technical field
The invention belongs to technical field of biological genetic engineering, and in particular to be disturbed by pig albumin, Porcine interferon-gamma and pig
Fusion protein of plain α compositions and preparation method thereof.
Background technology
Scale Compact Develop is rapidly growing in China in recent years, and China's live pig breeding stock and pork production are sure to occupy
First place in the world, traditional swine disease prevention and controls are far from the control for adapting to infectious disease in extensive intensive pig production production.I
Newly there are nearly 20 kinds of livestock and poultry infectious diseases in the past 20 years in state, plus original animal epidemic, aquaculture industry of China is caused huge
Economic loss.According to incompletely statistics, China is every year because various viral diseases cause mortality of livestock to be up to 15%-20%,
Economic loss reaches billions of members.
The prevention and treatment approach to porcine viral diseases mainly passes through vaccine inoculation and using antibiotic at present, but by
In breeding environment imperfection, virus variation and Abwehrkraft des Koepers change etc. reason, make traditional prevention and treatment approach by
Huge challenge, most of antibiotics and traditional oral antiviral medicament, due to medicament residue problem, to the mankind
Health is negatively affected;And traditional vaccine, high specific and side effect due to it, virus variation and new can not be resisted
The significant damage brought to pig aquaculture continuously emerges in type virus.
IFN is that the infection induced body of a viroid is produced with broad-spectrum antiviral, antitumor and with immunoregulation effect
Protein, nineteen fifty-seven, Issacs and Lindeman had found first, and it is a kind of multi-functional cell factor, with cell receptor knot
After conjunction, it can induce body and produce more species-specific proteins and enzyme, mainly by suppressing viral gene transcription and degraded virus
RNA is come the activity that suppresses the growth and breeding of virus and play antitumor grade.Now, it is known that α types IFN in vivo can be selectively
The infection cells such as virus are acted on, by suppressing the biosynthesis of the virus protein in infected cell, play wide spectrum and efficiently
Antivirus action.It is but faint without acting on or acting on to normal host cell.IFN-α main physiological activity is with suppression virus
Duplication, anti parasitic, the killing activity for suppressing various kinds of cell propagation, stimulating immunocyte.
γ types IFN is the T cell and the generation of NK cells by activating, and has relatively strong antiviral and immunoloregulation function.Largely
Research shows that interferon gamma also plays the adjustment effect of key in addition to broad-spectrum antiviral function, to immune system, so
IFN-γ is also known as immunological regulation interferon.Although various types of interferon can mediated cell to virus infection it is anti-
Should, but the immunoregulatory activity of interferon gamma is coordinating immune response and is determining to play more in the long-term antiviral state of body
Important effect, therefore interferon gamma has particularly important clinical value.
Seralbumin is the important component of blood plasma, is not easy to pass through glomerulus under normal circumstances, internal distributed pole it is wide and
There is no zymetology and immunologic competence, be preferable pharmaceutical carrier.Albumin fusion technology has the advantage that:Albumin and target egg
Linked in the cell through protein translation system by peptide bond in vain, be not required to extra extracorporeal treatment;The expression of albumin is higher,
The expression of destination protein can be improved after being merged with it;Albumin is one stable " inert protein ", after being merged with it
The stability of destination protein can be improved;Albumin fusion protein has longer drug half-life, by small molecular protein medicine
It can be expected to improve half-life period in blood with Albumin fusion.At present, in experimental animal after multiple protein and Albumin fusion
The extension of Half-life in vivo is confirmed.
The limitation of natural interferon and the current generally existing half-life short of artificial recombination interferon, half-life period are generally 2-4
Individual hour.Half-life short brings great inconvenience, the increase for the treatment of number of times, corresponding time cost and financial cost to treatment
Increase therewith, and the tenability limit of body is also possible to be broken the generation for causing adverse reaction.The main reason for half-life short
There are two:The too small tachytrophism in vivo of molecular weight of interferon, interferon especially recombinant interferon affinity is poor to be exempted from
Epidemic disease system is removed.
And common long-acting interferon is using polyethylene glycol fused interferon as representative on the market, only in the aspect of molecular weight
Part solves the problems, such as that interferon molecule amount is small and causes half-life short, while polyethylene glycol fused interferon cost is very
Height, it is unfavorable for clinically applying.
The content of the invention
In order to solve the above technical problems, the invention provides one kind by pig albumin, Porcine interferon-gamma and porcine interferon alpha group
Into fusion protein and preparation method thereof, and thus fusion protein with after freeze drying protectant mixture, it is freeze-dried to be prepared into
To a kind of Recombinant Swine long-acting interferon, the Recombinant Swine long-acting interferon is remarkably improved the half-life period of pig interferon, more commonly
The half-life period of pig interferon improves more than 24 times, and with broad-spectrum disease resistance toxic action and can improve the immune response of pig itself.
The technical scheme that the present invention takes is:
A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha, the amino of the fusion protein
Acid sequence table is as shown in the > of 400 < of SEQUENCE LISTING 1.
Present invention also offers the gene for encoding above-mentioned fusion protein, the nucleotides sequence list such as SEQUENCE of the gene
Shown in the > of 400 < of LISTING 2, genome 1 is designated as;Or as shown in the > of SEQUENCE LISTING400 < 3, it is designated as genome 2.
Fusion protein described in 2 equal codified of the genome 1 and the genome.Genome 2 is the nucleosides to genome 1
Acid sequence optimize after result, be considered as the gene in the expression system during usual codon adaptation indexI CAI=1.0
In be optimal high efficient expression state, CAI values are lower to show that expression is lower in host.Most preferable point of G/C content in gene
Cloth scope is 30~70%, and the scope is exceeded in any region can influence translation and transcriptional efficiency.Sent out using software detection
Existing pig albumin, porcine IFN γ, the codon of pig IFN-α original gene codon adaptation indexI (CAI) point in Escherichia coli
Not Wei 0.24,0.24,0.22, GC percentages be 43.7%, 39.2%, 59.1%;And by pig albumin, porcine IFN γ,
Obtained after pig IFN-α gene optimization each gene in Escherichia coli codon adaptation indexI (CAI) be 0.98,1.0,1.0, GC hundred
Divide ratio 50.3%, 45.4%, 55.6%.The utilization rate of low codon is significantly reduced by gene optimization, is avoided rare close
Influence of the numeral to protein expression, the G/C content of gene is improved, improves transcription and translation efficiency.
Present invention also offers the expression vector containing genome 1 or genome 2.
Further, the expression vector is the pET-32a coli expression carriers containing genome 1 or genome 2.
Present invention also offers the genetic engineering bacterium containing genome 1 or genome 2.
Further, the genetic engineering bacterium is pET-32a/rAlb-IFN γ-IFN α.
Host cell containing genome 1 or genome 2 falls within protection scope of the present invention, further, the place
Chief cell is e. coli host cell, and further, the e. coli host cell is BL21 (DE3) competent cell
Or BL21 (DE3) competent cell with pGro7 plasmids.
Present invention also offers a kind of Recombinant Swine long-acting interferon, the Recombinant Swine long-acting interferon is by described fusion egg
In vain with after freeze drying protectant mixture, it is freeze-dried to form.
The freeze drying protectant is glycerine, mannitol and sucrose, is buffer solution with 10mmol/L PBS, the final concentration of three
For glycerine 100mL/L, mannitol 0.12g/mL and sucrose 0.025g/mL.
The invention also discloses the preparation method of the fusion protein, the preparation method comprises the following steps:It will contain
The expression vector of genome 1 or genome 2 is imported into e. coli host cell, obtains genetic engineering bacterium, genetic engineering bacterium
The crude product of the fusion protein is obtained after IPTG induced expressions, fusion protein is can obtain after purified.
The expression vector is the pET-32a coli expression carriers containing genome 1 or genome 2;
The genetic engineering bacterium is pET-32a/rAlb-IFN γ-IFN α, and its preparation method is:
(1) primer is designed, obtained by reverse transcription or be manually respectively synthesized the pig albumin with flexible linker sequences,
The target gene of Porcine interferon-gamma, porcine interferon alpha;By flexible linker by pig albumin, Porcine interferon-gamma, porcine interferon alpha
Target gene connect, the nucleotides sequence list such as > institutes of 400 < of SEQUENCE LISTING 2 of the target gene after connection
Show or as shown in the > of 400 < of SEQUENCE LISTING 3;
(2) target gene after connection is connected on pET-32a plasmids and obtains expression vector;
(3) expression vector is imported into e. coli host cell, you can obtain genetic engineering bacterium pET-32a/rAlb-
IFNγ-IFNα。
The e. coli host cell is BL21 (DE3) competent cells or BL21 (DE3) senses with pGro7 plasmids
By state cell.
The method of the purifying is:The crude product of fusion protein is successively through affinity chromatography, anion-exchange chromatography and molecular sieve
Chromatographic purifying.
Described BL21 (DE3) competent cell with pGro7 plasmids is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise
Biology, article No. V205.
The acquisition methods of the genome 1 are:
A. design of primers
The primer sequence of pig albumin (Alb) is:
Upstream Alb-F1:CATGCCATGGGATACATACAAGAGTGA, with NcoI restriction enzyme sites;
Downstream Alb-R1:
ACCACCACCAGAACCACCACCACCGGCTAAGATCCCTCG, with flexible linker;
The primer sequence of Porcine interferon-gamma (IFN-γ) is:
Upstream IFN-γ-F1:
GGTGGTTCTGGTGGTGGTGGTTCTATGAGTTATACAACTTA, with flexible linker;
Downstream IFN-γ-R1:
ACCACCACCAGAACCACCACCACCTTTTGATGCTCTCTG, with flexible linker;
The primer sequence of porcine interferon alpha (IFN-α) is:
Upstream IFN-α-F1:
GGTGGTTCTGGTGGTGGTGGTTCTATGTGTTCCTATTTAAG, with flexible linker;
Downstream IFN-α-R1:CCCTCGAGCTCCTTCCTCCTG, with XhoI restriction enzyme sites;
B. RNA is extracted from pig liver, the target gene of pig Alb, porcine IFN γ and pig IFN-α is obtained by reverse transcription,
The gene order of three respectively as shown in the > of 400 < of SEQUENCE LISTING 4, the > of 400 < of SEQUENCE LISTING 5 and
Shown in the > of 400 < of SEQUENCE LISTING 6;
Respectively using pig Alb, porcine IFN γ and pig IFN-α target gene as template, and it is utilized respectively pig Alb, pig IFN-
The upstream and downstream primer of γ and pig IFN-α enter performing PCR amplification, respectively obtain the pig Alb for connecting flexible linker, porcine IFN γ and
Pig IFN-α gene.
PCR reaction systems and condition are:In 25 μ L overall reaction system, the μ L of template ribonucleic acid 1.5, upstream and downstream primer is each
0.5 μ L, reverse transcriptase 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;The reaction of the RT-PCR reactions
Condition is:50 DEG C of reverse transcriptions 30min, 95 DEG C of pre-degeneration 4min, into circulation;95 DEG C of denaturation 45s, 58 DEG C of annealing 45s, 72 DEG C are prolonged
1kb/min is stretched, is circulated 35 times, last 72 DEG C of extensions 10min.
C. rAlb-IFN γ genes are obtained using flexible linker connection pig Alb and porcine IFN γ target gene
The PCR reaction systems and reaction condition of connection be:In 25 μ L overall reaction system, connect flexible linker's
The μ L of Alb gene templates DNA 1, connect flexible linker 1 μ L, Alb sense primer of IFN-γ template DNA 0.5 μ L, IFN-
0.5 μ L, Taq archaeal dna polymerase of γ anti-sense primers 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;Connection
PCR reaction conditions are:95 DEG C of pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extension 1kb/
Min, totally 35 circulations;Last 72 DEG C of extensions 10min.
D. rAlb-IFN γ-IFN are obtained using flexible linker connections rAlb-IFN γ genes and pig IFN-α target gene
α genes
The PCR reaction systems and reaction condition of connection be:In 25 μ L overall reaction system, rAlb-IFN γ gene templates
The μ L of DNA 1, connect flexible linker 1 μ L, Alb sense primer of IFN-α template DNA 0.5 μ L, the μ of IFN-α anti-sense primer 0.5
L, Taq archaeal dna polymerase 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;Connecting PCR reaction conditions is:95
DEG C pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, totally 35 circulate;Finally
72 DEG C of extension 10min.
Genome 2 is artificial synthesized gene after being optimized to genome 1, the acquisition methods of the genome 2
For:
A. design of primers
The primer sequence of pig albumin (Alb) is:
Upstream Alb-F2:CATGCCATGGTGACACCTACAAATCTG, with NcoI restriction enzyme sites;
Downstream Alb-R2:
ACCACCACCAGAACCACCACCACCAGCCAGGATACCACG, with flexible linker;
The primer sequence of Porcine interferon-gamma (IFN-γ) is:
Upstream IFN-γ-F2:
GGTGGTTCTGGTGGTGGTGGTTCTATGTCTTACACCACCT, with flexible linker;
Downstream IFN-γ-R2:
ACCACCACCAGAACCACCACCACCTTTAGAAGCACGCTG, with flexible linker;
Porcine interferon alpha (IFN-α):
Upstream IFN-α-F2:
GGTGGTTCTGGTGGTGGTGGTTCTATGTGCTCTTACCTG, with flexible linker;
Downstream IFN-α-R2:
CCCTCGAGTTCTTTACGACGCAG, with XhoI restriction enzyme sites.
B. the target gene of the pig Alb, porcine IFN γ and pig IFN-α, the gene order of three is respectively such as SEQUENCE
Shown in the > of 400 < of LISTING 7, the > of 400 < of SEQUENCE LISTING 400 <, 8 > and SEQUENCE LISTING 9;
Respectively using pig Alb, porcine IFN γ and pig IFN-α target gene as template, and it is utilized respectively pig Alb, pig IFN-
The upstream and downstream primer of γ and pig IFN-α enter performing PCR amplification, respectively obtain the pig Alb for connecting flexible linker, porcine IFN γ and
Pig IFN-α gene.
PCR reaction systems and condition are:In 25 μ L overall reaction system, the μ L of genomic DNA 1, upstream and downstream primer is each
0.5 μ L, Taq archaeal dna polymerase 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;The RT-PCR reactions
Reaction condition is:95 DEG C of pre-degeneration 4min, into circulation;95 DEG C of denaturation 45s, 60 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, are followed
Ring 35 times, last 72 DEG C of extensions 10min.
C. rAlb-IFN γ genes are obtained using flexible linker connection pig Alb and porcine IFN γ target gene
The PCR reaction systems and reaction condition of connection be:In 25 μ L overall reaction system, connect flexible linker's
The μ L of Alb gene templates DNA 1, connect flexible linker 1 μ L, Alb sense primer of IFN-γ template DNA 0.5 μ L, IFN-
0.5 μ L, Taq archaeal dna polymerase of γ anti-sense primers 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;Connection
PCR reaction conditions are:95 DEG C of pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extension 1kb/
Min, totally 35 circulations;Last 72 DEG C of extensions 10min.
D. using flexible linker connections rAlb-IFN γ genes and pig IFN-α target gene obtain rAlb-IFN γ-
IFN-α gene
The PCR reaction systems and reaction condition of connection be:In 25 μ L overall reaction system, rAlb-IFN γ gene templates
The μ L of DNA 1, connect flexible linker 1 μ L, Alb sense primer of IFN-α template DNA 0.5 μ L, the μ of IFN-α anti-sense primer 0.5
L, Taq archaeal dna polymerase 2.5 μ L, dNTP Mix is 10 μ L, adds RNase Free water to 25 μ L;Connecting PCR reaction conditions is:95
DEG C pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extension 1kb/min, totally 35 circulate;Finally
72 DEG C of extension 10min.
Present invention also offers the application of the Recombinant Swine long-acting interferon, its long half time had up to more than 98 hours
Broad-spectrum disease resistance toxic action and the immune response that pig itself can be improved.
Compared with prior art, the present invention has the advantages that:
1. pig Alb, porcine IFN γ and pig IFN-α gene are realized into amalgamation and expression by flexible linker, interference is improved
Plain half-life period, compared with plain interferon, improve more than 24 times;
2. by being optimized to pig Alb, porcine IFN γ and pig IFN-α gene, pig Alb, porcine IFN γ and pig are improved
The expression quantity of IFN-α fusion protein.
3. using recombination bacillus coli pET-32a/rAlb-IFN γ-IFN α as expression bacterial strain, by introducing molecular chaperones
PGro7 plasmids, in protein expression, generation inclusion body is less, forms great amount of soluble albumen, avoids inclusion body denaturation and answers
The process of property, substantially reduce the time of expressing fusion protein;
4. the fusion protein disclosed by the invention being made up of pig Alb, porcine IFN γ and pig IFN-α not only has IFN-α
Broad-spectrum disease resistance toxic action, while significantly improve the immune response of pig itself.
Brief description of the drawings
Fig. 1 is that pig albumin gene, porcine interferon alpha gene and Porcine interferon-gamma gene RT-PCR in embodiment 1 are expanded
Result;Swimming lane M:DNA Marker DL2000;Swimming lane 1:Porcine interferon-gamma gene RT-PCR amplified productions;Swimming lane 2:Pig does
Disturb plain α genes RT-PCR amplified productions;Swimming lane 3:Pig albumin gene RT-PCR amplified productions;
Fig. 2 is the result of the PCR amplifications after pig Alb, the IFN-γ in embodiment 1 connect with the target gene of IFN-α;
Swimming lane M:DNA Marker DL10000;Swimming lane 1:Pig albumin gene, Porcine interferon-gamma gene are connected with porcine interferon alpha gene
Amplified production;
Fig. 3 is PCR amplifications and the double digestion qualification result of the positive colony plasmid in embodiment 1;Swimming lane M:DNA
Marker DL10000;Swimming lane 1:Recombinant plasmid double digestion result;Swimming lane 2:Plasmid PCR result;
Fig. 4 is the SDS-PAGE electrophoretic examinations results of the recombinant protein in embodiment 1;Swimming lane M:Albumen Marker;Swimming lane
1:Supernatant after bacterial cell disruption after recombinant bacterium induction;Swimming lane 2:Precipitated after bacterial cell disruption after recombinant bacterium induction;Swimming lane 3:It is unloaded
Control;
Fig. 5 is the Western Blot qualification results for the fusion protein that embodiment 1 obtains;Swimming lane M:Albumen Marker;Swimming
Road 1:Precipitated after recombinant bacterium induction is broken;Swimming lane 2:Supernatant after recombinant bacterium induction is broken;
Fig. 6 is that the Recombinant Swine long-acting interferon α as made from the fusion protein in embodiment 1 causes cell to VSV in embodiment 5
The inhibitory action of lesion;1 is VSV virus control wells;2 be HEp-2 cell control wells;A3-12 is gradient dilution (from right to left)
Human interferon standard items processing hole;B3-12 is that the Recombinant Swine long-acting interferon α of gradient dilution (from right to left) handles hole;
Fig. 7 is the Recombinant Swine long-acting interferon α intramuscular injection blood as made from the fusion protein in embodiment 1 in embodiment 8
Concentration-time changing curve.
Embodiment
Embodiment 1
A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha, its preparation method are as follows:
1. the acquisition of pig albumin (Alb), Porcine interferon-gamma (IFN-γ) and porcine interferon alpha (IFN-α) target gene with
Amplification
Design of primers:
Objective gene sequence design synthetic primer according to having been reported in Genebank is shown in Table 1, in the upstream of pig albumin
NcoI restriction enzyme sites and Linker sequences are introduced in primer and anti-sense primer respectively, sense primer and downstream in Porcine interferon-gamma
Linker sequences are introduced in primer respectively, Linker sequences are introduced respectively in the sense primer and anti-sense primer of porcine interferon alpha
With XhoI restriction enzyme sites.
Table 1PCR amplimers
RT-PCR obtains target gene:
RNA is extracted from pig liver tissue, the purpose base of pig Alb, porcine IFN γ and pig IFN-α is obtained by reverse transcription
Cause, the gene order of three respectively such as the > of 400 < of SEQUENCE LISTING 4, the > of 400 < of SEQUENCE LISTING 5 and
Shown in the > of 400 < of SEQUENCE LISTING 6;
RT-PCR reaction systems (25 μ L) are shown in Table 2
Table 2RT-PCR reaction systems
RNase Free water | 10μL |
dNTP Mix | 10μL |
Reverse transcriptase | 2.5μL |
Upstream and downstream primer | Each 0.5 μ L |
Geneome RNA | 1.5μL |
Response parameter is:50 DEG C of reverse transcriptions 30min, 95 DEG C of pre-degeneration 4min, into circulation:95 DEG C of denaturation 45s;58 DEG C are moved back
Fiery 45s, 72 DEG C of extension 1kb/min, totally 35 circulations;Last 72 DEG C of extensions 10min.
There is specific band through agarose gel electrophoresis in 1780bp, 560bp and 710bp or so in RT-PCR amplified productions,
Its result as shown in figure 1, explanation be prepared respectively the pig Alb for being connected to flexible linker sequences, porcine IFN γ and
The target gene of pig IFN-α.
2. the connection of target gene
Target gene is diluted to 10ug/mL, connects each section of target gene using over-lap PCR, 25 μ L reaction systems are such as
Shown in table 3, table 4:
Table 3rAlb-IFN γ PCR reaction systems
Table 4rAlb-IFN γ-IFN α PCR reaction systems
Response parameter is:95 DEG C of pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;58 DEG C of annealing 45s, 72 DEG C of extensions
1kb/min, totally 35 circulations;Last 72 DEG C of extensions 10min.
There is specific band through agarose gel electrophoresis in 2990bp or so in pcr amplification product, its result as shown in Fig. 2
Occur rAlb-IFN γ and IFN-α amplified production band in Fig. 2, because being connected in rAlb-IFN γ with IFN-α gene
During, there is non-specific responding.The nucleotide sequence of the obtained target gene such as > of 400 < of SEQUENCE LISTING 2
It is shown.
3. expression vector establishment
For target gene after selection connection after sequencing is errorless, PCR glue reclaims product uses NcoI with pET-32a plasmids
Double digestion and recovery are carried out with XhoI restriction enzymes, double digestion is done by 20 μ L systems in table 5:
The double digestion system of table 5
General buffer | 2μL |
Restriction enzyme (a pair) | 1μL+1μL |
Carrier or recovery fragment | 2ul |
RNase Free water | 14μL |
The digestion recovery product of target gene after connection and pET-32a plasmids is attached by the system in table 6,4
DEG C overnight connection:
The enzyme disjunctor system of table 6
Purpose fragment DNA | 10μL |
Expression vector | 3μL |
buffer | 2μL |
Ligase | 1μL |
RNase Free water | 4μL |
Connection product is converted into e. coli bl21 (DE3) competent cell, competent cell is coated on benzyl containing ammonia
The LB culture medium flat plates of penicillin are incubated overnight;Single bacterium colony on picking LB flat boards carries out target gene PCR identifications, positive colony
Bacteria plasmid is identified through NcoI and XhoI double digestions, is accredited as positive and is represented that engineering bacteria successfully constructs, PCR amplifications and double digestion production
Thing detects single band through agarose gel electrophoresis at 2990bp or so places, and its result is as shown in figure 3, illustrate successfully to obtain
PET-32a/rAlb-IFN γ-IFN α engineering bacteria.
4. the expression of recombinant protein
Picking engineering bacteria 37 DEG C of shaking table recovery 1h in the LB culture mediums containing 100 μ g/ml ampicillins, in LB culture mediums
Amplification culture 4h (OD=1.0) in (the μ g/ml containing ampicillin 100), adds final concentration of 100 μ g/ml IPTG, 32 DEG C lure
Lead expression 5h;Thalline is collected, through SDS-PAGE electrophoresis detections, its result is as shown in figure 4, it can be seen that recombinant bacterium lures
Supernatant is deposited in the visible predominant expression band in 127.8KD or so places after leading the bacterial cell disruption after 5h, illustrates in precipitation and supernatant
In equal successful expression fusion proteins.
Add mass volume ratio 1:Precipitation is resuspended in 1 PBS;- 20 DEG C precipitate 3 times in room temperature multigelation;4 DEG C of ultrasonic degradations
Bacterial precipitation, work 10s, is spaced 3S, ultrasonic 6min, and whole process repeats 3~4 times;4 DEG C, 12000r/min centrifugation 15min,
Supernatant, precipitation are taken respectively, obtain rough fusion protein.
5. fusion protein purification
5.1His affinity chromatography
After membrane filtration of the rough fusion protein with 0.22 μm of aperture, loading is by being connected to AKTA explorer 100
On protein purification system, the His affinity columns that have been balanced with Binding Buffer I (PBS) are washed away not with PBS
With reference to albumen, until A280nm is stable, then with Elution buffer I (50mM trishydroxymethylaminomethanes, 20~500mM
Imidazoles, PH8.0) elution, collect rAlb-IFN γ-IFN α protein peak.
5.2DEAE anion-exchange chromatography
(the 50mM trihydroxy methyls of Binding Buffer II are arrived into the albumen collected after His affinitive layer purifications displacement
Aminomethane, PH6.5) in after, DEAE anion exchange chromatography that loading has balanced by using Binding Buffer II, then
After crossing post to A280nm value stabilizations with Binding Buffer II, with (the 50mM trihydroxy methyl amino first of Elution Buffer II
Alkane, 1M NaCl, PH6.5) linear gradient elution, collect rAlb-IFN γ-IFN α protein peak.
5.3 sieve chromatography
Loading is by using (the 50mM of Binding Buffer III after the sample concentration that ion-exchange chromatography is collected into
Na2HPO4,0.15M NaCl, PH7.4) molecular sieve chromatographies of Superdex 200 have been balanced, washed with Binding Buffer III
It is de-, collect rAlb-IFN γ-IFN α protein peak.
5.4 sample identification
Determine rAlb-IFN γ-IFN α potency and specific activity, specific activity >=105IU/mg, albumen are qualified;It is aseptic subpackaged ,-
80 DEG C of preservations.The i.e. available fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha, its amino acid sequence
As shown in the > of 400 < of SEQUENCE LISTING 1.
Embodiment 2
A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha, other are with embodiment 1
E. coli bl21 therein (DE3) competent cell is replaced in order to which BL21 (DE3) competence with pGro7 plasmids is thin
Born of the same parents.The SDS-PAGE electrophoresis results of its fusion protein compare with embodiment 1,127.8KD or so places predominant expression bar in supernatant
Band is thicker, illustrates after introducing molecular chaperones pGro7, expression of the destination protein in supernatant is more preferable, obtained fusion protein amount
It is higher.The albumen of Bacillus coli expression is mostly present in inclusion body;By introducing molecular chaperones in bacterial strain is expressed, collaboration
Expressing protein correctly folds, and reaches solubility expression of protein.
Described BL21 (DE3) competent cell with pGro7 plasmids is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise
Biology, article No. V205.
Embodiment 3
A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha, its preparation method are as follows:
1. the acquisition of pig albumin (Alb), Porcine interferon-gamma (IFN-γ) and porcine interferon alpha (IFN-α) target gene with
Amplification
Pig Alb in embodiment 1, porcine IFN γ and pig IFN-α are optimized, artificially synthesized pig Alb, porcine IFN γ and
Pig IFN-α target gene, after optimization, the nucleotide sequence of three is respectively such as 400 < of SEQUENCE LISTING 7 >, SEQUENCE
Shown in the > of 400 < of LISTING 400 <, 8 > and SEQUENCE LISTING 9.
1.1 codon optimization
Genetic codon has 64 kinds, but most biological tendencies are in utilizing the part in these codons.Those
By the most frequent referred to as optimal codon (optimal codons) utilized, what those were not frequently utilized that is referred to as rare or utilizes
The low codon of rate (rare or low-usage codons).In fact, conventional do protein expression or every kind of biology of production
(including Escherichia coli, yeast, mammalian cell, plant cell and insect cell) all shows codon profit to a certain degree
Difference or preference.In Escherichia coli, yeast and drosophila to the expression efficiency of the gene containing optimal codon apparently higher than containing
The expression efficiency of the gene of the codon of poor efficiency.Therefore, in heterologous expression system, the preferences of codon are largely
On have impact on the expression of recombinant protein.Using preference codon (preferred codons) and avoid utilizing rare codon
Gene chemical synthesis is carried out, the redesign of this gene is codon optimization.Therefore, in the present embodiment to pig Alb, porcine IFN γ and
Pig IFN-α gene codon optimizes.
Interpretation of result after 1.2 codon optimizations
It is optimal efficient in the expression system to be considered as the gene during usual codon adaptation indexI (CAI)=1.0
Expression status, CAI values are lower to show that expression is lower in host.In gene G/C content most ideal distribution scope be 30~
70%, it can influence translation and transcriptional efficiency more than the scope in any region.Pig Alb, pig are found using software detection
The codon of IFN-γ and pig IFN-α original gene codon adaptation indexI (CAI) in Escherichia coli is respectively 0.24,
0.24th, 0.22, GC percentages are 43.7%, 39.2%, 59.1%;And by pig Alb, porcine IFN γ and pig IFN-α gene
Obtained after optimization recombination codon adaptation indexI (CAI) in Escherichia coli be respectively 0.98,1.0,1.0, GC percentages
50.3%th, 45.4%, 55.6%.The utilization rate of low codon is significantly reduced by gene optimization, avoids rare codon
Influence to protein expression, the G/C content of gene is improved, improve transcription and translation efficiency.
1.3 design of primers:
Table 7PCR amplimers
The genomic DNA of pig Alb after optimization, porcine IFN γ and pig IFN-α is diluted to 0.05mg/mL respectively.Utilize
PCR amplifications obtain target gene, and 25 μ L reaction systems are as shown in table 8:
Table 8PCR reaction systems
Response parameter is:95 DEG C of pre-degeneration 4min, into circulation:95 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extensions
1kb/min, totally 35 circulations;Last 72 DEG C of extensions 10min.
Pig Alb, porcine IFN γ and pig IFN-α pcr amplification product through agarose gel electrophoresis respectively 1780bp,
There is specific band in 560bp and 710bp or so, illustrate the pig for being connected to flexible linker after optimization has been prepared
Alb, porcine IFN γ and pig IFN-α target gene.
2. the connection of target gene
Target gene is diluted to 10ug/mL, connects each section of target gene using over-lap PCR, 25 μ L reaction systems are such as
Shown in table 9, table 10:
Table 9rAlb-IFN γ PCR reaction systems
Table 10rAlb-IFN γ-IFN-α PCR reaction systems
Response parameter is:95 DEG C of pre-degeneration 4min, into circulation:94 DEG C of denaturation 45s;60 DEG C of annealing 45s, 72 DEG C of extensions
1kb/min, totally 35 circulations;Last 72 DEG C of extensions 10min.
There is specific band in 2990bp or so through agarose gel electrophoresis and illustrates successfully to be connected in pcr amplification product
RAlb-IFN γ-IFN-α gene afterwards.The nucleotide sequence of the obtained target gene such as > of 400 < of SEQUENCE LISTING 3
It is shown.
3. expression vector establishment
The PCR errorless after sequencing of the target gene after connection glue reclaim product is selected to be used with pET-32a plasmids
NcoI, XhoI restriction enzyme carry out double digestion and recovery, and double digestion is done by 20 μ L systems in table 11:
The double digestion system of table 11
General buffer | 2μL |
Restriction enzyme (a pair) | 1μL+1μL |
Carrier or recovery fragment | 2ul |
RNase Free water | 14μL |
The digestion recovery product of target gene after connection and pET-32a plasmids is attached by the system in table 12,4
DEG C overnight connection:
Table 12
Purpose fragment DNA | 10μL |
Expression vector | 3μL |
buffer | 2μL |
Ligase | 1μL |
RNase Free water | 4μL |
Connection product is converted into e. coli bl21 (DE3) competent cell, competence is coated on the mould of benzyl containing ammonia
It is incubated overnight in the LB flat boards of element;The bacterium colony grown on LB flat boards is taken to identify target gene, positive colony bacteria plasmid warp through PCR
NcoI, XhoI double digestion are identified, are accredited as positive and are represented expression vector establishment success, PCR amplifications and double digestion product are through fine jade
There is single band at 2990bp or so places in sepharose electrophoresis, illustrates containing rAlb-IFN γ-IFN α fusion gene engineering bacterium
PET-32a/rAlb-IFN γ-IFN α successfully constructs.
4. the expression of recombinant protein
Picking engineering bacteria 37 DEG C of shaking table recovery 1h in the LB culture mediums containing 100 μ g/ml ampicillins, in LB culture mediums
Amplification culture 4h (OD=1.0) in (the μ g/ml containing ampicillin 100), adds final concentration of 100 μ g/ml IPTG, 32 DEG C lure
Lead expression 5h;Thalline is collected, through SDS-PAGE electrophoresis detections, supernatant is deposited in after the bacterial cell disruption after recombinant bacterium induction 5h
The visible predominant expression band in 127.8KD or so places, illustrate to have obtained recombinant protein in supernatant precipitates.
Add mass volume ratio 1:Precipitation is resuspended in 1 PBS;- 20 DEG C precipitate 3 times in room temperature multigelation;4 DEG C of ultrasonic degradations
Bacterial precipitation, work 10s, is spaced 3S, ultrasonic 6min, and whole process repeats 3~4 times;4 DEG C, 12000r/min centrifugation 15min,
Supernatant, precipitation are taken respectively, obtain rough fusion protein.
5. fusion protein purification
5.1His affinity chromatography
After membrane filtration of the rough fusion protein with 0.22 μm of aperture, loading is by being connected to AKTA explorer 100
On protein purification system, the His affinity columns that have been balanced with Binding Buffer I (PBS) are washed away not with PBS
With reference to albumen, until A280nm is stable, then with Elution buffer I (50mM trishydroxymethylaminomethanes, 20~500mM
Imidazoles, PH8.0) elution, collect rAlb-IFN γ-IFN α protein peak.
5.2DEAE anion-exchange chromatography
(the 50mM trihydroxy methyls of Binding Buffer II are arrived into the albumen collected after His affinitive layer purifications displacement
Aminomethane, PH6.5) in after, DEAE anion exchange chromatography that loading has balanced by using Binding Buffer II, then
After crossing post to A280nm value stabilizations with Binding Buffer II, with (the 50mM trihydroxy methyl amino first of Elution Buffer II
Alkane, 1M NaCl, PH6.5) linear gradient elution, collect rAlb-IFN γ-IFN α protein peak.
5.3 sieve chromatography
Loading is by using Binding Buffer III after the sample concentration that ion-exchange chromatography is collected into
(50mMNa2HPO4,0.15M NaCl, PH7.4) molecular sieve chromatographies of Superdex 200 have been balanced, with Binding Buffer
III elution, collects rAlb-IFN γ-IFN α protein peak.
5.4 sample identification
Determine rAlb-IFN γ-IFN α potency and specific activity, specific activity >=105IU/mg, albumen are qualified;Sterile point
Dress, -80 DEG C of preservations.The i.e. available fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha, its amino acid
Sequence is as shown in the > of 400 < of SEQUENCE LISTING 1.
Embodiment 4
A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha, other are with embodiment 3
E. coli bl21 therein (DE3) competent cell is replaced in order to which BL21 (DE3) competence with pGro7 plasmids is thin
Born of the same parents.The SDS-PAGE electrophoresis results of its fusion protein compare with embodiment 3,127.8KD or so places predominant expression bar in supernatant
Band is thicker, illustrates after introducing molecular chaperones pGro7, expression of the destination protein in supernatant is more preferable, obtained fusion protein amount
It is higher.The albumen of Bacillus coli expression is mostly present in inclusion body;By introducing molecular chaperones in bacterial strain is expressed, collaboration
Expressing protein correctly folds, and reaches solubility expression of protein.
Described BL21 (DE3) competent cell with pGro7 plasmids is purchased from Shanghai Jinan Technology Co., Ltd./glad hundred promise
Biology, article No. V205.
Embodiment 5
A kind of Recombinant Swine long-acting interferon α, by the fusion protein in embodiment 1,2,3,4 respectively with freeze drying protectant mixture
Afterwards, it is freeze-dried to form.The freeze drying protectant is glycerine, mannitol and sucrose, is buffer solution with 10mmol/L PBS,
Final concentration of glycerine 100mL/L, mannitol 0.12g/mL and the sucrose 0.025g/mL of three.
Embodiment 6
Embodiment 1~4 obtains the identification for the fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha
The quantitative detection of 6.1 protein contents
With Lowry methods, the standard protein that institute is examined and determine with Chinese food pharmaceutical biological product is made standard test, determines embodiment
1~4 obtained fusion protein concentration is all higher than 1.1mg/ml.
6.2SDS-PAGE electrophoresis detection
Compared with empty bacterium, fusion protein has the newly-increased protein band of a dense dye in 127.8KD or so, as shown in Figure 4.
6.3Western Blot results
Fusion protein in embodiment 1~4 is detected respectively, with the anti-porcine alpha-IFN (1 of abcam companies mouse:5000 dilutions) it is one
It is anti-, using goat anti-mouse IgG-HRP as secondary antibody (1:10000 dilutions).Recombinant Swine long-acting interferon α samples can be with anti-pig interferon
Alpha monoclonal antibodies occur specific reaction, 127.8KD or so place and specific band occur, as shown in Figure 5.
Embodiment 7
Bioactivity freeze-dried four parts of Recombinant Swine long-acting interferon α in embodiment 5
Suppress method according to few cells lesion, Hep-2 cells are made into 5 × 10 with culture medium5Cell/ml cells suspend
Liquid, per hole, inoculation 0.1ml moves into 96 porocyte culture plates.37 DEG C, 5%CO224h is cultivated, adds the Recombinant Swine length of various dose
Interferon-' alpha ' is imitated, inhales and abandons after 24h, then is inoculated with 100TCID50VSV viruses respectively.
Result of the test
As a result the Recombinant Swine long-acting interferon α for showing to obtain causes the lesion of HEp-2 cells to have obvious suppress to VSV
Effect.The lesion such as occurs cell rounding after undressed cell virus inoculation, comes off, is disintegrated.And the Recombinant Swine length obtained
After imitating the cell virus inoculation after interferon-' alpha ' processing, the Continuous Observation under inverted microscope, cellular morphology is normal, does not go out incumbent
What lesion, measures potency >=105IU/ml, as shown in Figure 6.
Embodiment 8
The four parts of Recombinant Swine long-acting interferon α obtained respectively by the fusion protein of embodiment 1~4 in embodiment 5 are freezed
The measure of half-life period of the agent (being designated as A, B, C, D respectively) in pig body
The blood concentration and time relationship of cytopathic-effect inhibition assay measure rAlb-IFN γ-IFN α
The pig (male and female half and half) that six body weight are roughly the same is taken, 2mg/ml Recombinant Swine long-acting interferons α is subcutaneously injected in neck
Freeze-dried 2ml, respectively in 1h, 2h, 4h, 8h, 16h, 26h, 44h, 79h, 144h venous blood collection, 4 DEG C of solidifications of blood sample, 3500rpm
Low-temperature centrifugation 10min separates serum, and each every pig blood sample of time point is to be measured in -20 DEG C of preservations.Determined using cytopathic-effect inhibition assay
The concentration of rAlb-IFN γ-IFN α in blood serum sample, carried out curve fitting and calculating parameter with DAS pharmacokinetics softwares.Parameter meter
Calculation the results are shown in Table 13.
Dominant dynamic parameters in serum after the Recombinant Swine long-acting interferon α intramuscular injection of table 13
As a result show that Recombinant Swine long-acting interferon α has longer half-life period.Half-life period can reach 98h or so after measured, compared with
Plain interferon improves about 24 times.
Embodiment 9
The freeze-dried measure influenceed on pig cell immune response of four parts of Recombinant Swine long-acting interferon α in embodiment 5
Take six roughly the same pork pigs of body weight to be divided into two groups, be designated as experimental group and control group;Experimental group neck is subcutaneously noted
The 2mg/ml Recombinant Swine long-acting interferon freeze-dried 2ml of α are penetrated, 2mL PBS is subcutaneously injected in control group neck, takes after injecting 4 weeks outside pig
All blood, take a blood weekly afterwards, separate lymphocyte using lymphocyte separation medium, lymphocyte passes through serum-free RPMI
After 1640 culture mediums wash 2 times, it is resuspended with complete medium, adjusts cell concentration as 2 × 106Individual/ml, 24 porocyte culture plates are every
Hole addition 1ml lymphocytes, 37 DEG C, 5%CO272h is cultivated, supernatant when collecting lymphocyte culture.ELISA detects culture supernatant
Middle IL-2, IL-4 content, is carried out, testing result is as shown in table 14 by kit specification:
Table 14ELISA detection each group pig cell immune responses are horizontal
As a result show after injecting Recombinant Swine long-acting interferon α, can significantly improve cell factor IL-2 in pig peripheral blood,
IL-4 content, cellullar immunologic response level is enhanced, significantly improves immunity level.
It is above-mentioned with reference to embodiment to a kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha and
The detailed description that its preparation method is carried out, is illustrative rather than limited, can be included according to limited scope some
Individual embodiment, therefore changing and modifications in the case where not departing from present general inventive concept, should belong within protection scope of the present invention.
SEQUENCE LISTING
<110>Wuhu Co., Ltd of Ying Tefeier biological products industrial research institute
<120>A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof
<130> 1
<160> 9
<170> PatentIn version 3.3
<210> 1
<211> 995
<212> PRT
<213>Pig albumin-interferon gamma-interferon alpha fusion protein
<400> 1
Asp Thr Tyr Lys Ser Glu Ile Ala His Arg Phe Lys Asp Leu Gly Glu
1 5 10 15
Gln Tyr Phe Lys Gly Leu Val Leu Ile Ala Phe Ser Gln His Leu Gln
20 25 30
Gln Cys Pro Tyr Glu Glu His Val Lys Leu Val Arg Glu Val Thr Glu
35 40 45
Phe Ala Lys Thr Cys Val Ala Asp Glu Ser Ala Glu Asn Cys Asp Lys
50 55 60
Ser Ile His Thr Leu Phe Gly Asp Lys Leu Cys Ala Ile Pro Ser Leu
65 70 75 80
Arg Glu His Tyr Gly Asp Leu Ala Asp Cys Cys Glu Lys Glu Glu Pro
85 90 95
Glu Arg Asn Glu Cys Phe Leu Gln His Lys Asn Asp Asn Pro Asp Ile
100 105 110
Pro Lys Leu Lys Pro Asp Pro Val Ala Leu Cys Ala Asp Phe Gln Glu
115 120 125
Asp Glu Gln Lys Phe Trp Gly Lys Tyr Leu Tyr Glu Ile Ala Arg Arg
130 135 140
His Pro Tyr Phe Tyr Ala Pro Glu Leu Leu Tyr Tyr Ala Ile Ile Tyr
145 150 155 160
Lys Asp Val Phe Ser Glu Cys Cys Gln Ala Ala Asp Lys Ala Ala Cys
165 170 175
Leu Leu Pro Lys Ile Glu His Leu Arg Glu Lys Val Leu Thr Ser Ala
180 185 190
Ala Lys Gln Arg Leu Lys Cys Ala Ser Ile Gln Lys Phe Gly Glu Arg
195 200 205
Ala Phe Lys Ala Trp Ser Leu Ala Arg Leu Ser Gln Arg Phe Pro Lys
210 215 220
Ala Asp Phe Thr Glu Ile Ser Lys Ile Val Thr Asp Leu Ala Lys Val
225 230 235 240
His Lys Glu Cys Cys His Gly Asp Leu Leu Glu Cys Ala Asp Asp Arg
245 250 255
Ala Asp Leu Ala Lys Tyr Ile Cys Glu Asn Gln Asp Thr Ile Ser Thr
260 265 270
Lys Leu Lys Glu Cys Cys Asp Lys Pro Leu Leu Glu Lys Ser His Cys
275 280 285
Ile Ala Glu Ala Lys Arg Asp Glu Leu Pro Ala Asp Leu Asn Pro Leu
290 295 300
Glu His Asp Phe Val Glu Asp Lys Glu Val Cys Lys Asn Tyr Lys Glu
305 310 315 320
Ala Lys His Val Phe Leu Gly Thr Phe Leu Tyr Glu Tyr Ser Arg Arg
325 330 335
His Pro Asp Tyr Ser Val Ser Leu Leu Leu Arg Ile Ala Lys Ile Tyr
340 345 350
Glu Ala Thr Leu Glu Asp Cys Cys Ala Lys Glu Asp Pro Pro Ala Cys
355 360 365
Tyr Ala Thr Val Phe Asp Lys Phe Gln Pro Leu Val Asp Glu Pro Lys
370 375 380
Asn Leu Ile Lys Gln Asn Cys Glu Leu Phe Glu Lys Leu Gly Glu Tyr
385 390 395 400
Gly Phe Gln Asn Ala Leu Ile Val Arg Tyr Thr Lys Lys Val Pro Gln
405 410 415
Val Ser Thr Pro Thr Leu Val Glu Val Ala Arg Lys Leu Gly Leu Val
420 425 430
Gly Ser Arg Cys Cys Lys Arg Pro Glu Glu Glu Arg Leu Ser Cys Ala
435 440 445
Glu Asp Tyr Leu Ser Leu Val Leu Asn Arg Leu Cys Val Leu His Glu
450 455 460
Lys Thr Pro Val Ser Glu Lys Val Thr Lys Cys Cys Thr Glu Ser Leu
465 470 475 480
Val Asn Arg Arg Pro Cys Phe Ser Ala Leu Thr Pro Asp Glu Thr Tyr
485 490 495
Lys Pro Lys Glu Phe Val Glu Gly Thr Phe Thr Phe His Ala Asp Leu
500 505 510
Cys Thr Leu Pro Glu Asp Glu Lys Gln Ile Lys Lys Gln Thr Ala Leu
515 520 525
Val Glu Leu Leu Lys His Lys Pro His Ala Thr Glu Glu Gln Leu Arg
530 535 540
Thr Val Leu Gly Asn Phe Ala Ala Phe Val Gln Lys Cys Cys Ala Ala
545 550 555 560
Pro Asp His Glu Ala Cys Phe Ala Val Glu Gly Pro Lys Phe Val Ile
565 570 575
Glu Ile Arg Gly Ile Leu Ala Gly Gly Gly Gly Ser Gly Gly Gly Gly
580 585 590
Ser Met Ser Tyr Thr Thr Tyr Phe Leu Ala Phe Gln Leu Cys Val Thr
595 600 605
Leu Cys Phe Ser Gly Ser Tyr Cys Gln Ala Pro Phe Phe Lys Glu Ile
610 615 620
Thr Ile Leu Lys Asp Tyr Phe Asn Ala Ser Thr Ser Gly Val Pro Asn
625 630 635 640
Gly Gly Pro Leu Phe Leu Glu Ile Leu Glu Asn Trp Lys Glu Glu Ser
645 650 655
Asp Lys Lys Ile Ile Gln Ser Gln Ile Val Ser Phe Tyr Phe Lys Phe
660 665 670
Phe Glu Ile Phe Lys Asp Asn Gln Ala Ile Gln Arg Ser Met Asp Val
675 680 685
Ile Lys Gln Asp Met Phe Gln Arg Phe Leu Asn Gly Ser Ser Gly Lys
690 695 700
Leu Asn Asp Phe Glu Lys Leu Val Lys Ile Pro Val Asp Asn Leu Gln
705 710 715 720
Ile Gln Arg Lys Ala Ile Ser Glu Leu Ile Lys Val Met Asn Asp Leu
725 730 735
Ser Pro Arg Ser Asn Leu Arg Lys Arg Lys Arg Ser Gln Thr Met Phe
740 745 750
Gln Gly Gln Arg Ala Ser Lys Gly Gly Gly Gly Ser Gly Gly Gly Gly
755 760 765
Ser Met Cys Ser Tyr Leu Arg His Arg Pro Glu Gly Arg Ser Ser Asn
770 775 780
Ile Leu Glu Ser Arg Val Thr Glu Ser Pro Thr Ser Ala Arg Thr Ala
785 790 795 800
Ala Ser Ala Arg Ser Pro Met Ala Pro Thr Ser Ala Phe Leu Thr Ala
805 810 815
Leu Val Leu Leu Ser Cys Asn Ala Ile Cys Ser Leu Gly Cys Asp Leu
820 825 830
Pro Gln Thr His Ser Leu Ala His Thr Arg Ala Leu Arg Leu Leu Ala
835 840 845
Gln Met Arg Arg Ile Ser Pro Phe Ser Cys Leu Asp His Arg Arg Asp
850 855 860
Phe Gly Phe Pro Gln Glu Ala Leu Gly Gly Asn Gln Val Gln Lys Ala
865 870 875 880
Gln Ala Met Ala Leu Val His Glu Met Leu Gln Gln Thr Phe Gln Leu
885 890 895
Phe Ser Thr Glu Gly Ser Ala Ala Ala Trp Asp Glu Ser Leu Leu His
900 905 910
Gln Phe Cys Thr Gly Leu Asp Gln Gln Leu Arg Asp Leu Glu Ala Cys
915 920 925
Val Met Gln Glu Ala Gly Leu Glu Gly Thr Pro Leu Leu Glu Glu Asp
930 935 940
Ser Ile Leu Ala Val Arg Lys Tyr Phe His Arg Leu Thr Leu Tyr Leu
945 950 955 960
Gln Glu Lys Ser Tyr Ser Pro Cys Ala Trp Glu Ile Val Arg Ala Glu
965 970 975
Val Met Arg Ala Phe Ser Ser Ser Thr Asn Leu Gln Asp Arg Leu Arg
980 985 990
Arg Lys Glu
995
<210> 2
<211> 2985
<212> DNA
<213>Genome 1
<400> 2
gatacataca agagtgaaat tgctcatcgg tttaaagatt tgggagaaca atatttcaaa 60
ggcctagtgc tgattgcctt ttctcagcat ctccagcaat gcccatatga agagcatgtg 120
aaattagtga gggaagtaac tgagtttgca aaaacatgtg ttgctgatga gtcagctgaa 180
aattgtgaca agtcaattca cactctcttt ggagataaat tatgtgcaat tccatccctt 240
cgtgaacact atggtgactt ggctgactgc tgtgaaaaag aagagcctga gagaaacgaa 300
tgcttcctcc aacacaaaaa tgataacccc gacatcccta aattgaaacc agaccctgtt 360
gctttatgcg ctgacttcca ggaagatgaa cagaagtttt ggggaaaata cctatatgaa 420
attgccagaa gacatcccta tttctacgcc ccagaactcc tttattatgc cattatatat 480
aaagatgttt tttcagaatg ctgccaagct gctgataaag ctgcctgcct gttaccaaag 540
attgagcatc tgagagaaaa agtactgact tccgccgcca aacagagact taagtgtgcc 600
agtatccaaa aattcggaga gagagctttc aaagcatggt cattagctcg cctgagccag 660
agatttccca aggctgactt tacagagatt tccaagatag tgacagatct tgcaaaagtc 720
cacaaggaat gctgccatgg tgacctgctt gaatgtgcag atgacagggc ggatcttgcc 780
aaatatatat gtgaaaatca agacacaatc tccactaaac tgaaggaatg ctgtgataag 840
cctctgttgg aaaaatccca ctgcattgct gaggcaaaaa gagatgaatt gcctgcagac 900
ctgaacccat tagaacatga ttttgttgaa gataaggaag tttgtaaaaa ctataaagaa 960
gcaaagcatg tcttcctggg cacgtttttg tatgagtatt caagaaggca cccagactac 1020
tctgtctcat tgctgctgag aattgccaag atatatgaag ccacactgga ggactgctgt 1080
gccaaagagg atcctccggc atgctatgcc acagtgtttg ataaatttca gcctcttgtg 1140
gatgagccta agaatttaat caaacaaaac tgtgaacttt ttgaaaaact tggagagtat 1200
ggattccaaa atgcgctcat agttcgttac accaagaaag taccccaagt gtcaactcca 1260
actcttgtgg aggtcgcaag aaaactagga ctagtgggct ctaggtgttg taagcgtcct 1320
gaagaagaaa gactgtcctg tgctgaagac tatctgtccc tggtcctgaa ccggttgtgc 1380
gtgttgcacg agaagacacc agtgagcgaa aaagttacca aatgctgcac agagtccttg 1440
gtgaacagac ggccttgctt ttctgctctg acaccagacg aaacatacaa acccaaagaa 1500
tttgttgagg gaaccttcac cttccatgca gacctatgca cacttcctga ggatgagaaa 1560
caaatcaaga agcaaactgc actcgttgag ttgttgaaac acaagcctca tgcaacagag 1620
gaacaactga gaactgtcct gggcaacttt gcagcctttg tacaaaagtg ctgcgccgct 1680
cctgaccatg aggcctgctt tgctgtggag ggtccgaaat ttgttattga aattcgaggg 1740
atcttagccg gtggtggtgg ttctggtggt ggtggttcta tgagttatac aacttatttc 1800
ttagcttttc agctttgcgt gactttgtgt ttttctggct cttactgcca ggcgcccttt 1860
tttaaagaaa taacgatcct aaaggactat tttaatgcaa gtacctcagg tgtacctaat 1920
ggtggacctc ttttcttaga aattttggag aattggaaag aggagagtga caaaaaaata 1980
attcagagcc aaattgtctc cttctacttc aaattctttg aaatcttcaa agataaccag 2040
gccattcaaa ggagcatgga tgtgatcaag caagacatgt ttcagaggtt cctaaatggt 2100
agctctggga aactgaatga cttcgaaaag ctggttaaaa ttccggtaga taatctgcag 2160
atccagcgca aagccatcag tgaactcatc aaagtgatga atgatctgtc accaagatct 2220
aacctaagaa agcggaagag aagtcagact atgttccaag gccagagagc atcaaaaggt 2280
ggtggtggtt ctggtggtgg tggttctatg tgttcctatt taagacacag gcctgaggga 2340
aggtcttcaa acatcctaga gagcagggtc acagagtcac ccacctcagc caggacagca 2400
gcatctgcaa ggtccccaat ggccccaacc tcagccttcc tcacggccct ggtgctgctc 2460
agctgcaatg ccatctgctc tctgggctgc gacctgcctc agacccacag cctggctcac 2520
accagggccc tgaggctcct ggcacaaatg aggagaatct cccccttctc ctgcctggac 2580
cacagaaggg actttggatt cccccaagag gccttggggg gcaaccaggt ccagaaggct 2640
caagccatgg ctctggtgca tgagatgctc cagcagacct tccagctctt cagcacagag 2700
ggctcggctg ctgcctggga tgagagcctc ctgcaccagt tctgcactgg actggatcag 2760
cagctcaggg acctggaagc ctgtgtcatg caggaggccg ggctggaagg gacccccctg 2820
ctggaggagg actccatcct ggctgtgagg aaatacttcc acagactcac cctctatctg 2880
caagagaaga gctacagccc ctgtgcctgg gagatcgtca gggcagaagt catgagagcc 2940
ttctcttcct ccacaaacct gcaagacaga ctcaggagga aggag 2985
<210> 3
<211> 2985
<212> DNA
<213>Genome 2
<400> 3
gacacctaca aatctgaaat cgctcaccgt ttcaaagacc tgggtgaaca gtacttcaaa 60
ggtctggttc tgatcgcttt ctctcagcac ctgcagcagt gcccgtacga agaacacgtt 120
aaactggttc gtgaagttac cgaattcgct aaaacctgcg ttgctgacga atctgctgaa 180
aactgcgaca aatctatcca caccctgttc ggtgacaaac tgtgcgctat cccgtctctg 240
cgtgaacact acggtgacct ggctgactgc tgcgaaaaag aagaaccgga acgtaacgaa 300
tgcttcctgc agcacaaaaa cgacaacccg gacatcccga aactgaaacc ggacccggtt 360
gctctgtgcg ctgacttcca ggaagacgaa cagaaattct ggggtaaata cctgtacgaa 420
atcgctcgtc gtcacccgta cttctacgct ccggaactgc tgtactacgc tatcatctac 480
aaagacgttt tctctgaatg ctgccaggct gctgacaaag ctgcttgcct gctgccgaaa 540
atcgaacacc tgcgtgaaaa agttctgacc tctgctgcta aacagcgtct gaaatgcgct 600
tctatccaga aattcggtga acgtgctttc aaagcttggt ctctggctcg tctgtcgcag 660
aggttcccga aagctgactt caccgaaatc tctaaaatcg ttaccgacct ggctaaagtt 720
cacaaagaat gctgccacgg tgacctgctg gaatgcgctg acgaccgtgc tgacctggct 780
aaatacatct gcgaaaacca ggacaccatc tctaccaaac tgaaagaatg ctgcgacaaa 840
ccgctgctgg aaaaatctca ctgcatcgct gaagctaaac gtgacgaact gccggctgac 900
ctgaacccgc tggaacacga cttcgttgaa gataaggaag tgtgcaaaaa ctacaaagaa 960
gctaaacacg ttttcctggg taccttcctg tacgaatact ctcgtcgtca cccggactac 1020
tctgtttctc tgctgctgcg tatcgctaaa atctacgaag ctaccctgga agactgctgc 1080
gctaaagaag acccgccggc ttgctacgct accgttttcg acaaattcca gccgctggtt 1140
gacgaaccga aaaacctgat caaacagaac tgcgaactgt tcgaaaaact gggtgaatac 1200
ggtttccaga acgctctgat cgttcgttac accaaaaaag ttccgcaggt ttctaccccg 1260
accctggttg aagttgctcg taaactgggt ctggttggtt ctcgttgctg caaacgtccg 1320
gaagaagaac gtctgtcttg cgctgaagac tacctgtctc tggttctgaa ccgtctgtgc 1380
gttctgcacg aaaaaacccc ggtttctgaa aaagttacca aatgctgcac cgaatctctg 1440
gttaaccgtc gtccgtgctt ctctgctctg accccggacg aaacctacaa accgaaagaa 1500
ttcgttgaag gtaccttcac cttccacgct gacctgtgca ccctgccgga agacgaaaaa 1560
cagatcaaaa aacagaccgc tctggttgaa ctgctgaaac acaaaccgca cgctaccgaa 1620
gaacagctgc gtaccgttct gggtaacttc gctgctttcg ttcagaaatg ctgcgctgct 1680
ccggaccacg aagcttgctt cgctgttgaa ggtccgaaat tcgttatcga aatccgtggt 1740
atcctggctg gtggtggtgg ttctggtggt ggtggttcta tgtcttacac cacctacttc 1800
ctggctttcc agctgtgcgt taccctgtgc ttctctggtt cttactgcca ggctccgttc 1860
ttcaaagaaa tcaccatcct gaaagactac ttcaacgctt ctacctctgg tgttccgaac 1920
ggtggtccgc tgttcctgga aatcctggaa aactggaaag aagaatctga caaaaaaatc 1980
atccagtctc agatcgtttc tttctacttc aaattcttcg aaatcttcaa agacaaccag 2040
gctatccagc gttctatgga cgttatcaaa caggacatgt tccagcgttt cctgaacggt 2100
tcttctggta aactgaacga cttcgaaaaa ctggttaaaa tcccggttga caacctgcag 2160
atccagcgta aagctatctc tgaactgatc aaagttatga acgacctgtc tccgcgttct 2220
aacctgcgta aacgtaaacg ttctcagacc atgttccagg gtcagcgtgc ttctaaaggt 2280
ggtggtggtt ctggtggtgg tggttctatg tgctcttacc tgcgtcaccg tccggaaggt 2340
cgttcttcta acatcctgga atctcgtgtt accgaatctc cgacctctgc tcgtaccgct 2400
gcttctgctc gttctccgat ggctccgacc tctgctttcc tgaccgctct ggttctgctg 2460
tcttgcaacg ctatctgctc tctgggttgc gacctgccgc agacccactc tctggctcac 2520
acccgtgctc tgcgtctgct ggctcagatg cgtcgtatct ctccgttctc ttgcctggac 2580
caccgtcgtg acttcggttt cccgcaggaa gctctgggtg gtaaccaggt tcagaaagct 2640
caggctatgg ctctggttca cgaaatgctg cagcagacct tccagctgtt ctctaccgaa 2700
ggttctgctg ctgcttggga cgaatctctg ctgcaccagt tctgcaccgg tctggaccag 2760
cagctgcgtg acctggaagc ttgcgttatg caggaagctg gtctggaagg taccccgctg 2820
ctggaagaag actctatcct ggctgttcgt aaatacttcc accgtctgac cctgtacctg 2880
caggaaaaat cttactctcc gtgcgcttgg gaaatcgttc gtgctgaagt tatgcgtgct 2940
ttctcttctt ctaccaacct gcaggaccgt ctgcgtcgta aagaa 2985
<210> 4
<211> 1749
<212> DNA
<213>Pig albumin
<400> 4
gatacataca agagtgaaat tgctcatcgg tttaaagatt tgggagaaca atatttcaaa 60
ggcctagtgc tgattgcctt ttctcagcat ctccagcaat gcccatatga agagcatgtg 120
aaattagtga gggaagtaac tgagtttgca aaaacatgtg ttgctgatga gtcagctgaa 180
aattgtgaca agtcaattca cactctcttt ggagataaat tatgtgcaat tccatccctt 240
cgtgaacact atggtgactt ggctgactgc tgtgaaaaag aagagcctga gagaaacgaa 300
tgcttcctcc aacacaaaaa tgataacccc gacatcccta aattgaaacc agaccctgtt 360
gctttatgcg ctgacttcca ggaagatgaa cagaagtttt ggggaaaata cctatatgaa 420
attgccagaa gacatcccta tttctacgcc ccagaactcc tttattatgc cattatatat 480
aaagatgttt tttcagaatg ctgccaagct gctgataaag ctgcctgcct gttaccaaag 540
attgagcatc tgagagaaaa agtactgact tccgccgcca aacagagact taagtgtgcc 600
agtatccaaa aattcggaga gagagctttc aaagcatggt cattagctcg cctgagccag 660
agatttccca aggctgactt tacagagatt tccaagatag tgacagatct tgcaaaagtc 720
cacaaggaat gctgccatgg tgacctgctt gaatgtgcag atgacagggc ggatcttgcc 780
aaatatatat gtgaaaatca agacacaatc tccactaaac tgaaggaatg ctgtgataag 840
cctctgttgg aaaaatccca ctgcattgct gaggcaaaaa gagatgaatt gcctgcagac 900
ctgaacccat tagaacatga ttttgttgaa gataaggaag tttgtaaaaa ctataaagaa 960
gcaaagcatg tcttcctggg cacgtttttg tatgagtatt caagaaggca cccagactac 1020
tctgtctcat tgctgctgag aattgccaag atatatgaag ccacactgga ggactgctgt 1080
gccaaagagg atcctccggc atgctatgcc acagtgtttg ataaatttca gcctcttgtg 1140
gatgagccta agaatttaat caaacaaaac tgtgaacttt ttgaaaaact tggagagtat 1200
ggattccaaa atgcgctcat agttcgttac accaagaaag taccccaagt gtcaactcca 1260
actcttgtgg aggtcgcaag aaaactagga ctagtgggct ctaggtgttg taagcgtcct 1320
gaagaagaaa gactgtcctg tgctgaagac tatctgtccc tggtcctgaa ccggttgtgc 1380
gtgttgcacg agaagacacc agtgagcgaa aaagttacca aatgctgcac agagtccttg 1440
gtgaacagac ggccttgctt ttctgctctg acaccagacg aaacatacaa acccaaagaa 1500
tttgttgagg gaaccttcac cttccatgca gacctatgca cacttcctga ggatgagaaa 1560
caaatcaaga agcaaactgc actcgttgag ttgttgaaac acaagcctca tgcaacagag 1620
gaacaactga gaactgtcct gggcaacttt gcagcctttg tacaaaagtg ctgcgccgct 1680
cctgaccatg aggcctgctt tgctgtggag ggtccgaaat ttgttattga aattcgaggg 1740
atcttagcc 1749
<210> 5
<211> 498
<212> DNA
<213>Porcine IFN γ
<400> 5
atgagttata caacttattt cttagctttt cagctttgcg tgactttgtg tttttctggc 60
tcttactgcc aggcgccctt ttttaaagaa ataacgatcc taaaggacta ttttaatgca 120
agtacctcag gtgtacctaa tggtggacct cttttcttag aaattttgga gaattggaaa 180
gaggagagtg acaaaaaaat aattcagagc caaattgtct ccttctactt caaattcttt 240
gaaatcttca aagataacca ggccattcaa aggagcatgg atgtgatcaa gcaagacatg 300
tttcagaggt tcctaaatgg tagctctggg aaactgaatg acttcgaaaa gctggttaaa 360
attccggtag ataatctgca gatccagcgc aaagccatca gtgaactcat caaagtgatg 420
aatgatctgt caccaagatc taacctaaga aagcggaaga gaagtcagac tatgttccaa 480
ggccagagag catcaaaa 498
<210> 6
<211> 678
<212> DNA
<213>Pig IFN-α
<400> 6
atgtgttcct atttaagaca caggcctgag ggaaggtctt caaacatcct agagagcagg 60
gtcacagagt cacccacctc agccaggaca gcagcatctg caaggtcccc aatggcccca 120
acctcagcct tcctcacggc cctggtgctg ctcagctgca atgccatctg ctctctgggc 180
tgcgacctgc ctcagaccca cagcctggct cacaccaggg ccctgaggct cctggcacaa 240
atgaggagaa tctccccctt ctcctgcctg gaccacagaa gggactttgg attcccccaa 300
gaggccttgg ggggcaacca ggtccagaag gctcaagcca tggctctggt gcatgagatg 360
ctccagcaga ccttccagct cttcagcaca gagggctcgg ctgctgcctg ggatgagagc 420
ctcctgcacc agttctgcac tggactggat cagcagctca gggacctgga agcctgtgtc 480
atgcaggagg ccgggctgga agggaccccc ctgctggagg aggactccat cctggctgtg 540
aggaaatact tccacagact caccctctat ctgcaagaga agagctacag cccctgtgcc 600
tgggagatcg tcagggcaga agtcatgaga gccttctctt cctccacaaa cctgcaagac 660
agactcagga ggaaggag 678
<210> 7
<211> 1749
<212> DNA
<213>Pig albumin
<400> 7
gacacctaca aatctgaaat cgctcaccgt ttcaaagacc tgggtgaaca gtacttcaaa 60
ggtctggttc tgatcgcttt ctctcagcac ctgcagcagt gcccgtacga agaacacgtt 120
aaactggttc gtgaagttac cgaattcgct aaaacctgcg ttgctgacga atctgctgaa 180
aactgcgaca aatctatcca caccctgttc ggtgacaaac tgtgcgctat cccgtctctg 240
cgtgaacact acggtgacct ggctgactgc tgcgaaaaag aagaaccgga acgtaacgaa 300
tgcttcctgc agcacaaaaa cgacaacccg gacatcccga aactgaaacc ggacccggtt 360
gctctgtgcg ctgacttcca ggaagacgaa cagaaattct ggggtaaata cctgtacgaa 420
atcgctcgtc gtcacccgta cttctacgct ccggaactgc tgtactacgc tatcatctac 480
aaagacgttt tctctgaatg ctgccaggct gctgacaaag ctgcttgcct gctgccgaaa 540
atcgaacacc tgcgtgaaaa agttctgacc tctgctgcta aacagcgtct gaaatgcgct 600
tctatccaga aattcggtga acgtgctttc aaagcttggt ctctggctcg tctgtcgcag 660
aggttcccga aagctgactt caccgaaatc tctaaaatcg ttaccgacct ggctaaagtt 720
cacaaagaat gctgccacgg tgacctgctg gaatgcgctg acgaccgtgc tgacctggct 780
aaatacatct gcgaaaacca ggacaccatc tctaccaaac tgaaagaatg ctgcgacaaa 840
ccgctgctgg aaaaatctca ctgcatcgct gaagctaaac gtgacgaact gccggctgac 900
ctgaacccgc tggaacacga cttcgttgaa gataaggaag tgtgcaaaaa ctacaaagaa 960
gctaaacacg ttttcctggg taccttcctg tacgaatact ctcgtcgtca cccggactac 1020
tctgtttctc tgctgctgcg tatcgctaaa atctacgaag ctaccctgga agactgctgc 1080
gctaaagaag acccgccggc ttgctacgct accgttttcg acaaattcca gccgctggtt 1140
gacgaaccga aaaacctgat caaacagaac tgcgaactgt tcgaaaaact gggtgaatac 1200
ggtttccaga acgctctgat cgttcgttac accaaaaaag ttccgcaggt ttctaccccg 1260
accctggttg aagttgctcg taaactgggt ctggttggtt ctcgttgctg caaacgtccg 1320
gaagaagaac gtctgtcttg cgctgaagac tacctgtctc tggttctgaa ccgtctgtgc 1380
gttctgcacg aaaaaacccc ggtttctgaa aaagttacca aatgctgcac cgaatctctg 1440
gttaaccgtc gtccgtgctt ctctgctctg accccggacg aaacctacaa accgaaagaa 1500
ttcgttgaag gtaccttcac cttccacgct gacctgtgca ccctgccgga agacgaaaaa 1560
cagatcaaaa aacagaccgc tctggttgaa ctgctgaaac acaaaccgca cgctaccgaa 1620
gaacagctgc gtaccgttct gggtaacttc gctgctttcg ttcagaaatg ctgcgctgct 1680
ccggaccacg aagcttgctt cgctgttgaa ggtccgaaat tcgttatcga aatccgtggt 1740
atcctggct 1749
<210> 8
<211> 498
<212> DNA
<213>Porcine IFN γ
<400> 8
atgtcttaca ccacctactt cctggctttc cagctgtgcg ttaccctgtg cttctctggt 60
tcttactgcc aggctccgtt cttcaaagaa atcaccatcc tgaaagacta cttcaacgct 120
tctacctctg gtgttccgaa cggtggtccg ctgttcctgg aaatcctgga aaactggaaa 180
gaagaatctg acaaaaaaat catccagtct cagatcgttt ctttctactt caaattcttc 240
gaaatcttca aagacaacca ggctatccag cgttctatgg acgttatcaa acaggacatg 300
ttccagcgtt tcctgaacgg ttcttctggt aaactgaacg acttcgaaaa actggttaaa 360
atcccggttg acaacctgca gatccagcgt aaagctatct ctgaactgat caaagttatg 420
aacgacctgt ctccgcgttc taacctgcgt aaacgtaaac gttctcagac catgttccag 480
ggtcagcgtg cttctaaa 498
<210> 9
<211> 678
<212> DNA
<213>Pig IFN-α
<400> 9
atgtgctctt acctgcgtca ccgtccggaa ggtcgttctt ctaacatcct ggaatctcgt 60
gttaccgaat ctccgacctc tgctcgtacc gctgcttctg ctcgttctcc gatggctccg 120
acctctgctt tcctgaccgc tctggttctg ctgtcttgca acgctatctg ctctctgggt 180
tgcgacctgc cgcagaccca ctctctggct cacacccgtg ctctgcgtct gctggctcag 240
atgcgtcgta tctctccgtt ctcttgcctg gaccaccgtc gtgacttcgg tttcccgcag 300
gaagctctgg gtggtaacca ggttcagaaa gctcaggcta tggctctggt tcacgaaatg 360
ctgcagcaga ccttccagct gttctctacc gaaggttctg ctgctgcttg ggacgaatct 420
ctgctgcacc agttctgcac cggtctggac cagcagctgc gtgacctgga agcttgcgtt 480
atgcaggaag ctggtctgga aggtaccccg ctgctggaag aagactctat cctggctgtt 540
cgtaaatact tccaccgtct gaccctgtac ctgcaggaaa aatcttactc tccgtgcgct 600
tgggaaatcg ttcgtgctga agttatgcgt gctttctctt cttctaccaa cctgcaggac 660
cgtctgcgtc gtaaagaa 678
Claims (10)
- A kind of 1. fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha, it is characterised in that:The fusion The amino acid sequence table of albumen is as shown in the > of 400 < of SEQUENCE LISTING 1.
- A kind of 2. gene for encoding fusion protein as claimed in claim 1, it is characterised in that the nucleotide sequence of the gene Table is designated as genome 1 as shown in the > of 400 < of SEQUENCE LISTING 2;Or as shown in the > of 400 < of SEQUENCE LISTING 3, It is designated as genome 2.
- 3. the expression vector containing gene as claimed in claim 2.
- 4. the genetic engineering bacterium containing gene as claimed in claim 2.
- 5. a kind of Recombinant Swine long-acting interferon, it is characterised in that the Recombinant Swine long-acting interferon is as melting described in claim 1 It is freeze-dried to form after hop protein and freeze drying protectant mixture.
- 6. the preparation method of fusion protein according to claim 1, it is characterised in that the preparation method includes following step Suddenly:Expression vector described in claim 3 is imported into e. coli host cell, obtains genetic engineering bacterium, genetic engineering Bacterium obtains the crude product of the fusion protein after IPTG induced expressions, and fusion protein is can obtain after purified.
- 7. preparation method according to claim 6, it is characterised in that the genetic engineering bacterium is pET-32a/rAlb-IFN γ-IFN α, its preparation method are:(1) primer is designed, is obtained by reverse transcription or is manually respectively synthesized the pig albumin with flexible linker sequences, pig does Disturb the target gene of plain γ, porcine interferon alpha;By flexible linker by pig albumin, Porcine interferon-gamma, porcine interferon alpha mesh Gene connect, the nucleotides sequence list of the target gene after connection as shown in the > of 400 < of SEQUENCE LISTING 2 or As shown in the > of 400 < of SEQUENCE LISTING 3;(2) target gene after connection is connected on pET-32a plasmids and obtains expression vector;(3) expression vector is imported into e. coli host cell, you can obtain genetic engineering bacterium pET-32a/rAlb-IFN γ-IFNα。
- 8. the preparation method according to claim 6 or 7, it is characterised in that the e. coli host cell is BL21 (DE3) competent cell or BL21 (DE3) competent cell with pGro7 plasmids.
- 9. the preparation method according to claim 6 or 7, it is characterised in that the method for the purifying is:Fusion protein it is thick Product successively purify through affinity chromatography, anion-exchange chromatography and sieve chromatography.
- 10. the application of Recombinant Swine long-acting interferon according to claim 5, it is characterised in that the Recombinant Swine is long-acting dry The long half time of element is disturbed up to more than 98 hours, there is broad-spectrum disease resistance toxic action and the immune response of pig itself can be improved.
Priority Applications (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710676594.1A CN107353347A (en) | 2017-08-09 | 2017-08-09 | A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof |
CN201810768603.4A CN108840951A (en) | 2017-08-09 | 2018-07-13 | A kind of fusion protein and preparation method thereof being made of pig albumin, Porcine interferon-gamma and porcine interferon alpha |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201710676594.1A CN107353347A (en) | 2017-08-09 | 2017-08-09 | A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
CN107353347A true CN107353347A (en) | 2017-11-17 |
Family
ID=60288435
Family Applications (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201710676594.1A Pending CN107353347A (en) | 2017-08-09 | 2017-08-09 | A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and porcine interferon alpha and preparation method thereof |
CN201810768603.4A Withdrawn CN108840951A (en) | 2017-08-09 | 2018-07-13 | A kind of fusion protein and preparation method thereof being made of pig albumin, Porcine interferon-gamma and porcine interferon alpha |
Family Applications After (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810768603.4A Withdrawn CN108840951A (en) | 2017-08-09 | 2018-07-13 | A kind of fusion protein and preparation method thereof being made of pig albumin, Porcine interferon-gamma and porcine interferon alpha |
Country Status (1)
Country | Link |
---|---|
CN (2) | CN107353347A (en) |
Cited By (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112370524A (en) * | 2020-12-11 | 2021-02-19 | 北京大伟嘉生物技术股份有限公司 | Antiviral composition and preparation method and application thereof |
CN118165126A (en) * | 2024-05-14 | 2024-06-11 | 北京伟杰信生物科技有限公司 | Fusion protein of recombinant porcine interferon lambda 1, porcine interferon gamma and porcine Fc (KiH) and application thereof |
CN118165124A (en) * | 2024-05-14 | 2024-06-11 | 北京伟杰信生物科技有限公司 | Fusion protein of recombinant porcine interferon lambda 1, porcine interferon gamma and porcine Fc and application thereof |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN114539426B (en) * | 2022-03-02 | 2023-07-07 | 山东仙普爱瑞科技股份有限公司 | Fusion protein containing interferon alpha, recombinant strain expressing fusion protein and preparation method of recombinant strain |
-
2017
- 2017-08-09 CN CN201710676594.1A patent/CN107353347A/en active Pending
-
2018
- 2018-07-13 CN CN201810768603.4A patent/CN108840951A/en not_active Withdrawn
Cited By (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN112370524A (en) * | 2020-12-11 | 2021-02-19 | 北京大伟嘉生物技术股份有限公司 | Antiviral composition and preparation method and application thereof |
CN118165126A (en) * | 2024-05-14 | 2024-06-11 | 北京伟杰信生物科技有限公司 | Fusion protein of recombinant porcine interferon lambda 1, porcine interferon gamma and porcine Fc (KiH) and application thereof |
CN118165124A (en) * | 2024-05-14 | 2024-06-11 | 北京伟杰信生物科技有限公司 | Fusion protein of recombinant porcine interferon lambda 1, porcine interferon gamma and porcine Fc and application thereof |
CN118165126B (en) * | 2024-05-14 | 2024-07-19 | 北京伟杰信生物科技有限公司 | Fusion protein of recombinant porcine interferon lambda 1, porcine interferon gamma and porcine Fc (KiH) and application thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108840951A (en) | 2018-11-20 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CN108840951A (en) | A kind of fusion protein and preparation method thereof being made of pig albumin, Porcine interferon-gamma and porcine interferon alpha | |
CN107353346A (en) | A kind of fusion protein being made up of pig albumin and Porcine interferon-gamma and preparation method thereof and a kind of Recombinant Swine long-acting interferon γ | |
CN108840952A (en) | A kind of fusion protein and preparation method thereof being made of Chicken Albumin, chicken interferon gamma and chicken interferon α | |
CN107266587A (en) | A kind of recombinant bovine long-acting interferon α and prepare fusion protein of this long-acting interferon and preparation method thereof | |
CN108840950A (en) | A kind of fusion protein and preparation method thereof being made of pig interleukin 2 and 6, Porcine interferon-gamma and porcine interferon alpha | |
CN107383205A (en) | Pig albumin interferon-' alpha ' interleukin-22 fusion protein, preparation method and its encoding gene, a boar long-acting interferon | |
CN108794644A (en) | A kind of fusion protein and preparation method thereof being made of cattle interleukins-2 2, Bov IFN γ and Bov IFN α | |
CN108794645A (en) | A kind of fusion protein and preparation method thereof being made of bovine albumin, Bov IFN γ and Bov IFN α | |
CN107365390A (en) | A kind of fusion protein being made up of pig albumin, Porcine interferon-gamma and pig interleukin 2 and 6 and preparation method thereof | |
CN107245110A (en) | A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interferon-tau and preparation method thereof | |
CN107254000A (en) | A kind of fusion protein being made up of sheep albumin and sheep interferon gamma and preparation method thereof and a kind of restructuring sheep long-acting interferon γ | |
CN108822221A (en) | A kind of fusion protein and preparation method thereof being made of Chicken Albumin, chicken interferon gamma and recombinant chIL-2 | |
CN108840934A (en) | A kind of recombination sheep long-acting interferon τ and the fusion protein for preparing this long-acting interferon and preparation method thereof | |
CN107383204A (en) | A kind of fusion protein being made up of sheep interleukin 2, sheep interferon gamma and sheep interferon-tau and preparation method thereof | |
CN107286257A (en) | A kind of Recombinant Swine long-acting interferon α and prepare fusion protein of this long-acting interferon and preparation method thereof | |
CN107353350A (en) | A kind of fusion protein being made up of bovine albumin and Bov IFN γ and preparation method thereof and a kind of recombinant bovine long-acting interferon γ | |
CN109053897A (en) | A kind of fusion protein and preparation method thereof being made of recombinant chIL-2, chicken interferon gamma and chicken interferon α | |
CN107266586A (en) | A kind of Recombinant Swine long-acting interferon γ and prepare this long-acting interferon γ fusion protein and preparation method thereof | |
CN107266588A (en) | A kind of fusion protein being made up of bovine albumin, Bov IFN γ and cattle interleukins-2 2 and preparation method thereof | |
CN107245109A (en) | A kind of fusion protein being made up of sheep albumin, sheep interferon gamma and sheep interleukin 2 and preparation method thereof | |
CN107286256A (en) | A kind of recombination chicken long-acting interferon γ and prepare this long-acting interferon γ fusion protein and preparation method thereof | |
CN107286253A (en) | A kind of fusion protein being made up of OVA and chicken interferon gamma and preparation method thereof and a kind of recombination chicken long-acting interferon γ | |
CN107286252A (en) | A kind of recombination chicken long-acting interferon α and prepare fusion protein of this long-acting interferon and preparation method thereof | |
CN107353349A (en) | A kind of Recombinant Swine long-acting interferon and prepare fusion protein of this long-acting interferon and preparation method thereof | |
CN107266589A (en) | A kind of fusion protein being made up of dog albumin, dog interferon γ and canine leucocyte interleukin 2 and preparation method thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
WD01 | Invention patent application deemed withdrawn after publication |
Application publication date: 20171117 |
|
WD01 | Invention patent application deemed withdrawn after publication |